Browse Category

Company News News 27 October 2025 - 1 November 2025

3M’s 2025 Comeback: MMM Stock Surges on Turnaround – Will the Rally Last?

3M’s 2025 Comeback: MMM Stock Surges on Turnaround – Will the Rally Last?

Deep Dive: 3M’s Road Ahead – Turnaround Triumph or Value Trap? Stock Performance Recap (2025 Rally After Years of Laggards) 3M’s share price performance in 2025 has been a bright spot following a rough decade for the company’s investors. After languishing and dramatically underperforming the S&P 500 in the late 2010s and early 2020s, MMM found a bottom in late 2022–2023 amid pandemic disruptions and legal overhangs. The stock dipped into the low $100s at its trough. Fast-forward to 2025, and 3M has staged a notable comeback: shares rose from the ~$130 level in January to the mid-$160s by October,
Plug Power Stock Skyrocketed 170% on Hydrogen Hype – Now It’s Sliding: Can PLUG Rebound?

Plug Power Stock Soars 170% on Hydrogen Hype – Will the Rally Last? (Oct 31, 2025 Update)

A green hydrogen production facility (illustration) – Plug Power and competitors are building large-scale electrolyzer projects and hydrogen plants worldwide ts2.tech ir.plugpower.com. Stock Price & Recent Performance Plug Power’s stock has been on a roller coaster. After languishing around $1.50–$1.60 in late summer 2025, it shot up ~170% to ~$4.58 by early October ts2.tech. This surge was driven by broader “hydrogen hype,” short-squeeze buying, and news of large contracts ts2.tech. By Oct 23 the stock cooled off to the high-$2s ts2.tech. In the past week (Oct 24–30), PLUG edged down further: from ~$2.95 (Oct 24 close) to $2.65 (Oct 30)
Western Digital (WDC) Stock Soars in 2025: SanDisk Legacy & 2026 Outlook

Western Digital Stock Skyrockets on AI Demand – Analysts Eye Even Bigger Gains

WDC Near Record Highs on Earnings News Western Digital stock has been on a tear in October. On Oct. 23 it closed around $126.63 ts2.tech; by Oct. 29, the price had spiked into the $141 range (an intraday record) on heavy volume marketbeat.com. In pre-market trading Oct. 30 it dipped slightly (~$138) public.com but remained near multi-year highs. This rally was punctuated by the after-hours release of Q1 FY2026 results on Oct. 30. Q1 FY2026 Results Exceed Expectations The fiscal Q1 (ended Oct 3, 2025) results were a blowout. On an adjusted basis, EPS came in at $1.78 versus $1.58
EMCOR Group (EME) Delivers Record Q3 – So Why Are Shares Crashing?

EMCOR Group (EME) Delivers Record Q3 – So Why Are Shares Crashing?

EMCOR’s Oct 30 report painted an overwhelmingly positive picture: “We had an outstanding third quarter,” CEO Tony Guzzi told analysts businesswire.com, noting 16.4% revenue growth and an all-time high backlog. Net income was $295.4M (diluted EPS $6.57) businesswire.com, well above last year’s $270.3M ($5.80 EPS). In fact, EMCOR narrowly beat the street’s EPS consensus (~$6.53) nasdaq.com – though it fell slightly below a higher Zacks estimate of $6.65 timesunion.com. The full-year outlook was boosted: revenues now expected ~$16.75 B (vs prior ~$16.65B) with EPS at least $25.00 businesswire.com nasdaq.com. Guzzi highlighted that performance obligations (“booked” future work) jumped to $12.61B businesswire.com,
Cleveland-Cliffs’ Rollercoaster: CLF Stock Soars on Rare-Earth Hype, Plunges on Share Sale – What’s Next?

Cleveland-Cliffs’ Rollercoaster: CLF Stock Soars on Rare-Earth Hype, Plunges on Share Sale – What’s Next?

Cleveland-Cliffs Stock Price: October 30 Update and Recent Performance Cleveland-Cliffs’ stock price has been on a wild ride in recent weeks. On October 30, 2025, CLF shares tumbled roughly 12% intraday, trading around the $12.30 level – a sharp decline triggered by the company’s surprise decision to sell new stock. The sell-off came immediately after Cliffs announced an underwritten public offering of 75 million common shares (with an option for 11.25 million more) priced at about $12.85 per share investing.com investing.com. This move would raise approximately $964 million in gross proceeds for the company, but it also significantly increases the
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround?

HBIO Stock in Freefall – and a Nasdaq Lifeline Harvard Bioscience’s share price has been on a wild ride in 2025, mostly downhill. The stock now hovers around 40 cents, down from the mid-$2 range a year ago fintel.io. In fact, HBIO has lost nearly 84% of its value year-over-year fintel.io, an astonishing collapse that reflects both company-specific struggles and the broader market rout in small-cap biotech names. Shares cratered to an intraday low of $0.28 in mid-2025 amid intense selling pressure investing.com, before staging a modest rebound. Even after some recovery, HBIO remains deep in penny stock territory, a
Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Anthropic’s Private Shares Soar to $185 Amid AI Frenzy – $183B Valuation, Major Deals & $1.5B Lawsuit

Private Valuation and Growth Surge Anthropic remains privately held, but secondary-market pricing gives a clear picture of investor sentiment. According to Forge Global data, Anthropic’s derived share price hit $185.90 on Oct. 29, 2025 forgeglobal.com. That figure implies an eye-watering ~$241 billion valuation forgeglobal.com. Remarkably, Forge’s charts show the price jumped about +1,555% in one week during late October forgeglobal.com. (Hiive, another private market site, similarly values Anthropic around $190–200 per share.) This caps a year of rapid growth: Anthropic’s Sept 2025 press release notes that its revenue run-rate exploded from roughly $1 billion in early 2025 to $5 billion by August 2025
Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

Constellation Software (CSU.TO) Stock Plunges on Founder’s Exit – Analysts See 58% Upside

Constellation Software’s share price has tumbled in October amid market volatility and a sudden leadership shakeup. After closing at C$3,453.88 on Oct. 29, 2025 stockanalysis.com, the stock stands far below its recent peak. The 52-week trading range is roughly C$3,390 – C$5,300 stockanalysis.com, underscoring the sharp pullback. (Constellation is Canada’s largest publicly traded “vertical market software” company – a niche of mission-critical, industry-specific software – with a market capitalization around C$79.5B stockanalysis.com.) The recent decline accelerated a slide that began in late September; shares fell ~10% over Oct. 27–29 (from C$3,844 on Oct. 27 to C$3,453 on Oct. 29 stockanalysis.com).
Retail Shock: Target Slashes 1,800 Jobs — Is the Economy in Danger?

Retail Shock: Target Slashes 1,800 Jobs — Is the Economy in Danger?

Target’s Major Layoff Plan Target’s management disclosed the cuts in a memo to employees on Oct. 23. The moves mainly affect corporate and managerial roles — store and supply-chain workers are untouched reuters.com. Fiddelke, a 20-year veteran who takes over from CEO Brian Cornell next year, wrote that Target has “too many layers and overlapping work” that have made it “harder to bring ideas to life,” so simplifying the structure was essential reuters.com businessinsider.com. He asked Minneapolis HQ staff to work from home the following week as changes are implemented. Target says those losing jobs will be paid through early
Nordex Stock Skyrockets on Surprise Profit Upgrade – Wind Turbine Maker Defies Industry Woes

Nordex Stock Skyrockets on Surprise Profit Upgrade – Wind Turbine Maker Defies Industry Woes

Strong Q3 Drives Upbeat Forecast Nordex SE delivered a positive surprise in Q3 2025, nearly doubling its operating profit from a year earlier. Preliminary EBITDA for the quarter hit €136 million, yielding an 8.0% margin – up sharply from €72 million and a 4.3% margin in Q3 2024 deraktionaer.de. Buoyed by this result, Nordex’s management announced an upward revision to its full-year EBITDA margin forecast on October 27. The company now projects a 7.5–8.5% EBITDA margin for 2025 (vs. 5.0–7.0% prior) tradingview.com, while leaving other guidance (e.g. revenue of €7.4–7.9 billion) unchanged deraktionaer.de. Nordex credited strong operational execution across both its turbine projects and
28 October 2025
Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Stock Skyrockets on Saudi Arabia Deal Announcement Co-Diagnostics’ stock price erupted on Monday after the company unveiled a strategic joint venture in the Middle East. Shares of the small-cap diagnostics firm opened around $0.59 and quickly soared, at one point up 133% to about $0.82 by mid-morning benzinga.com. The surge only intensified as trading progressed – by late morning the stock was up 148% and still climbing, prompting a wave of retail trader excitement online menafn.com. CODX ultimately closed at $1.07, marking a stunning +206% one-day gain finance.yahoo.com. For context, the stock had ended the prior trading day at roughly $0.35 nasdaq.com, and was down over 70% in
Lululemon Stock Surges on NFL Deal – Is the Turnaround Starting?

Lululemon Stock Surges on NFL Deal – Is the Turnaround Starting?

Lululemon announced its first-ever NFL apparel collection on Oct. 27, sending shares up ~5% in premarket trading reuters.com. Founder Chip Wilson publicly called for a board overhaul and hinted at activist involvement au.investing.com. Major analysts have cut their targets (Bernstein now $190, Morgan Stanley $185) on weak U.S. trends intellectia.ai intellectia.ai. The stock closed around $178.17 on Oct. 24 stockanalysis.com (down ~53% YTD nasdaq.com) and jumped toward ~$189 by Oct. 27 pre-market. Lululemon’s P/E is only ~12×, well below the luxury retail norm, suggesting it may be heavily undervalued simplywall.st nasdaq.com. NFL Partnership Sparks Rally On Oct. 27 Lululemon disclosed
1 9 10 11 12 13 15
Go toTop